Oxford Drug Design reports major in vivo milestone for novel cancer therapy - PharmaTimes Data shows potential route to overcoming resistance in aggressive colorectal tumours

#AIdrugdiscovery #drugdiscovery #RandD #oncology #OxfordDrugDesign #invivo #novelcancertherapy #aggressivecolorectaltumours #colorectaltumours #GenAIplatform #colorectalcancer #benchmarktherapy #KRASmutations #RASdrivencolorectalcancers #CRUKScotlandInstitute
zurl.co/tYDJO